Summary by Moomoo AI
Raymond M. Jordt, the Chief Business Officer of Altimmune, Inc., completed a purchase of 917 shares of common stock on July 31, 2024. The transaction was carried out directly with the shares valued at $5.41 each. Following this acquisition, Jordt's total direct holdings in the company increased to 14,660 shares. The transaction is part of a grant, award, or other acquisition, as per the transaction code description provided.